To include your compound in the COVID-19 Resource Center, submit it here.

Banzel rufinamide regulatory update

In June, Health Canada approved Banzel rufinamide from Eisai for adjunctive treatment of

Read the full 133 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE